Implementation Of Comprehensive High-dose Aphasia Treatment (CHAT)
Funder
National Health and Medical Research Council
Funding Amount
$1,065,665.00
Summary
Aphasia is a communication disability that occurs in up to 30% of stroke survivors. Most people with aphasia do not currently receive the amount and type of treatment they need. The aim of this research is to evaluate the implementation of this comprehensive high dose aphasia treatment in clinical settings. Implementation will occur through partnerships with service providers, consumer organisations and clinical networks. This work will provide a new way to manage aphasia and improve lives.
Enhancing Hepatitis C Testing And Treatment Among People Who Inject Drugs In Drug Treatment Settings: The ETHOS III Study
Funder
National Health and Medical Research Council
Funding Amount
$1,349,604.00
Summary
Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally.